[
    [
        {
            "time": "",
            "original_text": "[增持评级]医药生物行业周报：在整体市场调整中建议积极关注医药板块的优质公司",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业周报",
                    "市场调整",
                    "优质公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业周报：在整体市场调整中建议积极关注医药板块的优质公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]医药行业周报：市场波动首选医药 重点推荐乐普医疗、恒瑞医药等",
            "features": {
                "keywords": [
                    "强于大市",
                    "医药行业",
                    "市场波动",
                    "乐普医疗",
                    "恒瑞医药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]医药行业周报：市场波动首选医药 重点推荐乐普医疗、恒瑞医药等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]医药生物行业研究周报：板块估值持续消化 抓住成长股机遇",
            "features": {
                "keywords": [
                    "强于大市",
                    "医药生物",
                    "行业研究",
                    "板块估值",
                    "成长股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[强于大市评级]医药生物行业研究周报：板块估值持续消化 抓住成长股机遇",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]